Announcing Earth Day Plus (Apr 22 to May 3) – VC-Founder Matchup + Live Sessions. Learn More

Prellis Biologics

Harnessing the power of the human immune system to build next generation medicines.

Team

Melanie Matheu

CTO & Founder

Kevin Chapman

CSO

Yelda Kaya

CBO

Matt Niemiec

Controller

Company details

Prellis is leveraging their unique approach to tissue engineering to support the first use of synthetic human tissue for de novo therapeutic antibody discovery.

Get In Touch with Prellis Biologics

Please tell us a little bit about yourself and why you'd like to get connected. Prellis Biologics + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.